Lundbeck fine: industry outraged over messy patent system
This article was originally published in Scrip
Executive Summary
Lundbeck has branded as "erroneous" the European Commission's decision to fine it for anticompetitive behavior, while the European industry federation , EFPIA, has claimed that the affair flags up deficiencies in the European patent litigation system and raises cause for concern with implications for innovation, patient welfare and economic growth.